pharma · Leukemia, Lymphocytic, Acute, B-Cell · Prostate Cancer Indications
Shenzhen Second People's
Shenzhen Second People's Hospital
Shenzhen Second People's clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 2
- Drugs
- 4
- Patents
- 0
Shenzhen Second People's projects
2 ClinicalTrials.gov programs sponsored by Shenzhen Second People's.
Shenzhen Second People's has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Shenzhen Second People's have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.